Sign Out
3.75 mg/11.25 mg: Hypersensitivity to leuprorelin, any of the excipients or other synthetic GnRH analogues or GnRH derivatives.
Undiagnosed abnormal vaginal bleeding.
In girls with central precocious puberty (for 11.25 mg only): Pregnancy and lactation; Undiagnosed vaginal bleeding.
Use in Pregnancy: Use in females who are or may become pregnant while receiving the drug as ENANTONE L.P. 3.75 mg/11.25 mg may cause fetal harm when administered to pregnant females.
Use in Lactation: Use in females who are breast feeding. Because of the lack of data regarding ENANTONE L.P 3.75 mg/11.25 mg excretion in milk and its potential effects on nursing babies, ENANTONE L.P. 3.75 mg/11.25 mg should not be used on nursing mother.
30 mg: Patients with a history of hypersensitivity to the ingredients of the preparation or synthetic LH-RH or LH-RH derivatives.
Continue with Google